2021 - 2022 日常診療におけるReal World Dataを活用した新規TDM支援ソフトの開発
2015 - 2018 抗結核活性を有する新規天然化合物のヒット・トゥ・リード研究
2014 - 2018 新規抗結核薬のリード化合物探索研究
全件表示
論文 (15件):
Takemasa Takii, Tomohiro Hasegawa, Saotomo Itoh, Shinji Maeda, Takayuki Wada, Yasuhiro Horita, Akihito Nishiyama, Sohkichi Matsumoto, Naoya Ohara, Aoi Kimishima, et al. Analysis of the drug target of the anti-tuberculosis compound OCT313: phosphotransacetylase is a potential drug target for anti-mycobacterial agents. mSphere. 2025
Masaya Nagamizu, Yuji Hotta, Masato Noda, Daigaku Nakamura, Masayuki Hori, Yuto Otsuka, Ryuhei Takemoto, Yasuhiro Horita, Eri Wakita, Nobuyuki Morishita, et al. Association of doses based on body constitutional parameters with the efficacy of micafungin in candidemia. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2025. 31. 4. 102654-102654
Iida M, Horita Y, Asaoka M, Ohashi K, Noda M, Wachino C, Hirose T, Nomura Y, Hisada Y, Nagamizu M, et al. Evaluation of target area under the concentration-time curve of vancomycin in an initial dosing design: a retrospective cohort study. Journal of Antimicrobial Chemotherapy. 2024
Horita Y, Asaoka M, Iida M, Kato H, Wachino C, Mitamura K, Ohashi K, Mimura Y, Hotta Y, Kataoka T, et al. Development and Evaluation of a Novel Software Program, SAKURA-TDM, for Area Under the Concentration-Time Curve-Guided Vancomycin Dosing: A Short Communication. Therapeutic Drug Monitoring. 2023. 45. 2. 245-250
Tomita N, Hotta Y, Ito H, Naiki-Ito A, Matsuta K, Yamamoto Y, Ohashi K, Hayakawa T, Sanagawa A, Horita Y, et al. High Preoperative Serum Strontium Increase the Risk of Acute Kidney Injury after Cardiopulmonary Bypass. Clinical and Experimental Nephrology. 2022
Comparative study of the effects of antituberculosis drugs and antiretroviral drugs on cytochrome P450 3A4 and P-glycoprotein
World Biomedical Frontiers 2015